Skip to main content
. 2014 Nov 18;9(11):e106143. doi: 10.1371/journal.pone.0106143

Figure 2. SFRP1 protein expression in α-SMA+ myofibroblasts in NAT, TA and CRC areas in representative photomicrographs.

Figure 2

SFRP1 protein expression (red immunofluorescent staining) in whole slide (A) which includes NAT (white arrow), TA (yellow arrow) and CRC (red arrow). Both in NAT region (in 9/9 cases; B) and TA (in 4/9 cases; C) α-SMA+ myofibroblasts (E, F) showed retained SFRP1 expression (85.73±12.61%) (B, C; merged pictures: H, I). Around most CRC glands α-SMA+ myofibroblasts (green immunofluorescent staining; G) showed reduced (P<0.001) SFRP1 expression (27.65%±18.27%; in 9/9 cases) (D; merged picture: J).